P

Inventor

ASHWELL SUSAN

US49 patents
⚠️ This page may combine multiple inventors who share the name “ASHWELL SUSAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

FORMA THERAPEUTICS INC

23 patents
US10550098B2Feb 4, 2020

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

FORMA THERAPEUTICS INC17 citations94
US10414752B2Sep 17, 2019

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

FORMA THERAPEUTICS INC19 citations94
US10005734B2Jun 26, 2018

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

FORMA THERAPEUTICS INC25 citations94
US9834539B2Dec 5, 2017

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

FORMA THERAPEUTICS INC28 citations94
US9815817B2Nov 14, 2017

Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors

FORMA THERAPEUTICS INC24 citations94
US9771349B2Sep 26, 2017

Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

FORMA THERAPEUTICS INC27 citations94
US9624175B2Apr 18, 2017

Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

FORMA THERAPEUTICS INC25 citations94
US9624216B2Apr 18, 2017

Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors

FORMA THERAPEUTICS INC26 citations94
US11498913B2Nov 15, 2022

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

FORMA THERAPEUTICS INC4 citations84
US10889567B2Jan 12, 2021

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

FORMA THERAPEUTICS INC5 citations84
US10550099B2Feb 4, 2020

Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors

FORMA THERAPEUTICS INC4 citations84
US10807976B2Oct 20, 2020

Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors

FORMA THERAPEUTICS INC2 citations73
US10577329B2Mar 3, 2020

Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

FORMA THERAPEUTICS INC4 citations73
US10407419B2Sep 10, 2019

Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors

FORMA THERAPEUTICS INC5 citations73
US11497743B2Nov 15, 2022

Treating patients harboring an isocitrate dehydrogenase 1 (IDH-1) mutation

FORMA THERAPEUTICS INC3 citations72
US12275715B2Apr 15, 2025

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

FORMA THERAPEUTICS INC0 citations63
US11963956B2Apr 23, 2024

Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1)

FORMA THERAPEUTICS INC1 citations62
US11738018B2Aug 29, 2023

Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1)

FORMA THERAPEUTICS INC1 citations62
US11576906B2Feb 14, 2023

Inhibiting mutant IDH-1

FORMA THERAPEUTICS INC1 citations62
US11376246B2Jul 5, 2022

Inhibiting mutant IDH-1

FORMA THERAPEUTICS INC1 citations62
US11311527B2Apr 26, 2022

Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1)

FORMA THERAPEUTICS INC1 citations62
US11013734B2May 25, 2021

Treating patients harboring an isocitrate dehydrogenase-1 (IDH-1) mutation

FORMA THERAPEUTICS INC1 citations62
US11013733B2May 25, 2021

Inhibiting mutant isocitrate dehydrogenase 1 (mlDH-1)

FORMA THERAPEUTICS INC1 citations62

ELAN PHARM INC

11 patents

WYETH CORP

6 patents

FORMA TM2 INC

4 patents

(unassigned)

2 patents

ATHENA NEUROSCIENCES INC

2 patents

ASTRAZENECA AB

1 patent